TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
MDXG

MiMedx Group Inc

Healthcare · Biotechnology

4.70$ -1.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow MDXG
Line item 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – +11.9% +26.8% +163.9% -43.1% +0.0% -210.1% – – – +147.2% +11.8%
– +2,401.3% +118.3% +0.0% +1.9% +60.3% +3.5% -8.3% +25.7% +28.6% +100.2% +5.4% +20.0% +0.0% +9.7% -31.7% -21.9% -15.3% +76.3% +146.3%
– – – – – +41.7% +53.0% +136.7% +90.6% +47.5% +4.9% +19.5% – – -18.3% +17.3% -10.5% +33.9% -0.2% -3.2%
– – – – – – +25.1% +326.1% +96.6% -23.4% -13.1% -162.3% – -71.9% +85.7% -27.0% +4.2% – – –
– – – +0.0% -89.2% -350.9% – – – – – -108.4% – – -207.8% – – – – –
– +409.9% -69.3% +0.0% -57.9% +220.6% +31.0% +266.9% +9.5% +127.8% +6.5% -17.4% +83.7% +0.0% -76.5% +45.1% -16.6% -26.0% -15.3% -38.6%
– – -160.1% +0.0% -57.5% +363.3% -9.3% +375.0% +301.6% -94.4% +1,622.4% -53.8% +70.8% +0.0% -50.6% -25.5% -21.6% -19.0% +344.7% -28.1%
– – – – – – – – – – – – – – – -98.6% -54.7% +53.1% – –
– -60.2% -56.8% +110.0% +40.7% -38.0% +75.0% +476.9% -113.8% +617.7% -71.3% +526.7% -94.4% +210.8% -88.2% +222.3% -75.0% +699.6% -72.2% +18.1%
– – – – – – -107.3% -87.0% +103.7% +430.8% -83.6% -71.6% -89.7% – -145.2% -99.9% +7.9% -100.0% – -96.8%
– +12,685.9% -42.7% +0.0% +218.4% +44.9% -34.8% +514.7% -105.3% +1,588.0% -77.5% +640.9% -85.2% +0.0% – -105.3% -82.7% +1,377.6% +299.1% -84.2%
– -58,461.1% – – – – -4.7% +1,313.3% -93.3% -822.7% – -170.8% – +0.0% +35.8% -136.4% – – +39.7% +175.3%
– – – – – – – – – -8.9% +35.9% +227.7% -55.4% +2.4% -257.8% – – – +160.3% +13.1%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?